ClinVar Genomic variation as it relates to human health
NM_005630.3(SLCO2A1):c.1807C>T (p.Arg603Ter)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_005630.3(SLCO2A1):c.1807C>T (p.Arg603Ter)
Variation ID: 225477 Accession: VCV000225477.8
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 3q22.1 3: 133935781 (GRCh38) [ NCBI UCSC ] 3: 133654625 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline May 25, 2017 Mar 10, 2024 Mar 22, 2022 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_005630.3:c.1807C>T MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_005621.2:p.Arg603Ter nonsense NC_000003.12:g.133935781G>A NC_000003.11:g.133654625G>A NG_031964.3:g.121404C>T LRG_841:g.121404C>T LRG_841t1:c.1807C>T LRG_841p1:p.Arg603Ter - Protein change
- R603*
- Other names
- -
- Canonical SPDI
- NC_000003.12:133935780:G:A
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
-
Trans-Omics for Precision Medicine (TOPMed) 0.00000
The Genome Aggregation Database (gnomAD), exomes 0.00004
Exome Aggregation Consortium (ExAC) 0.00005
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
SLCO2A1 | - | - |
GRCh38 GRCh37 |
274 | 310 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Pathogenic/Likely pathogenic (3) |
criteria provided, multiple submitters, no conflicts
|
Mar 22, 2022 | RCV000490280.6 | |
Pathogenic (1) |
no assertion criteria provided
|
Feb 13, 2024 | RCV001527663.4 | |
Pathogenic (1) |
criteria provided, single submitter
|
Mar 3, 2022 | RCV002517444.3 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Pathogenic
(Mar 18, 2016)
|
criteria provided, single submitter
Method: reference population
|
Hypertrophic osteoarthropathy, primary, autosomal recessive, 2
Affected status: unknown
Allele origin:
germline
|
Soonchunhyang University Bucheon Hospital, Soonchunhyang University Medical Center
Accession: SCV000267512.1
First in ClinVar: May 25, 2017 Last updated: May 25, 2017 |
Number of individuals with the variant: 1
Age: 40-69 years
Ethnicity/Population group: East Asian
Geographic origin: South Korean
|
|
Likely pathogenic
(Mar 22, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Hypertrophic osteoarthropathy, primary, autosomal recessive, 2
Affected status: yes
Allele origin:
germline
|
3billion
Accession: SCV002318623.1
First in ClinVar: Apr 02, 2022 Last updated: Apr 02, 2022 |
Comment:
Stop-gained (nonsense): predicted to result in a loss or disruption of normal protein function through protein truncation. The predicted truncated protein may be shortened by … (more)
Stop-gained (nonsense): predicted to result in a loss or disruption of normal protein function through protein truncation. The predicted truncated protein may be shortened by less than 10% . The variant has been reported at least twice as pathogenic/likely pathogenic with clinical assertions and evidence for the classification (ClinVar ID: VCV000225477, PMID:24153155). It is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency:0.0000364). Therefore, this variant is classified as likely pathogenic according to the recommendation of ACMG/AMP guideline. (less)
Clinical Features:
Clubbing (present) , Diarrhea (present) , Hyperhidrosis (present) , Thickened skin (present)
|
|
Pathogenic
(Mar 03, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV003525286.2
First in ClinVar: Feb 07, 2023 Last updated: Feb 14, 2024 |
Comment:
ClinVar contains an entry for this variant (Variation ID: 225477). For these reasons, this variant has been classified as Pathogenic. This premature translational stop signal … (more)
ClinVar contains an entry for this variant (Variation ID: 225477). For these reasons, this variant has been classified as Pathogenic. This premature translational stop signal has been observed in individual(s) with hypertrophic osteoarthropathy (PMID: 24153155, 24929850). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is present in population databases (rs776813259, gnomAD 0.03%). This sequence change creates a premature translational stop signal (p.Arg603*) in the SLCO2A1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 41 amino acid(s) of the SLCO2A1 protein. (less)
|
|
Pathogenic
(Feb 13, 2024)
|
no assertion criteria provided
Method: literature only
|
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL DOMINANT
Affected status: not provided
Allele origin:
germline
|
OMIM
Accession: SCV001738782.4
First in ClinVar: Jun 26, 2021 Last updated: Mar 10, 2024 |
Comment on evidence:
PHOAR2-Enteropathy Syndrome For discussion of the c.1807C-T transition (c.1807C-T, NM_005630) in exon 13 of the SLCO2A1 gene, resulting in an arg603-to-ter (R603X) substitution, that was … (more)
PHOAR2-Enteropathy Syndrome For discussion of the c.1807C-T transition (c.1807C-T, NM_005630) in exon 13 of the SLCO2A1 gene, resulting in an arg603-to-ter (R603X) substitution, that was found in compound heterozygous state in 2 Japanese sisters (patients 4 and 5) with chronic nonspecific ulcers (CNSU) of the stomach, duodenum, and ileum, who also exhibited acne, large joint arthralgias, and hyperhidrosis (PHOAR2E; 614441) by Umeno et al. (2015), see 601460.0004. Umeno et al. (2015) also reported an 18-year-old Japanese girl (patient 15) with anemia and CNSU of the duodenum and ileum who was compound heterozygous for R603X and a splice site mutation in SLCO2A1 (c.940+1G-A; 601460.0005), and a 59-year-old Japanese woman (patient 10) with CNSU of the ileum who was compound heterozygous for R603X and a c.421G-T transversion in exon 4, resulting in a glu141-to-ter (E141X; 601460.0023) substitution. The latter 2 patients did not exhibit features of PHO. Functional analysis in transfected HEK293 cells demonstrated that none of the mutants was able to take up PGE, indicating loss of function as a PGE transporter. For discussion of the c.1807C-T transition (c.1807C-T, NM_005630.2) in exon 13 of the SLCO2A1 gene, resulting in an arg603-to-ter (R603X) substitution, that was found in compound heterozygous state in a 19-year-old Korean man (family 2) with primary hypertrophic osteoarthropathy (PHO) by Lee et al. (2016), see 601460.0005. In 2 Chinese men (P17 and P33) with features of PHO, including digital clubbing and periostosis, Li et al. (2017) identified compound heterozygosity for the R603X substitution and another mutation in the SLCO2A1 gene: in P17, the second mutation was a c.1624C-T transition in exon 11, resulting in an arg542-to-cys (R542C; 601460.0024) substitution at a highly conserved residue; and in P33, the second mutation was a c.1106-1G-A transition in intron 8 (601460.0025). The R542C variant was present at very low minor allele frequency (0.0002221) in the ExAC database. Neither man was reported to have gastrointestinal symptoms. In a review of 46 Japanese patients from 43 families with CNSU and mutation in the SLCO2A1 gene, Umeno et al. (2018) noted that the R603X variant was present in 20 (22%) of 92 alleles, making it the second most frequent mutation identified. In a Chinese man (family 12) with PHO, Xu et al. (2021) identified homozygosity for the R603X substitution. His heterozygous father exhibited only pachydermia and periostosis, whereas his heterozygous mother was clinically unaffected. The proband in family 12 had been previously studied by Li et al. (2017) as P15, and was reported to have gastrointestinal hemorrhage and anemia. Autosomal Dominant Primary Hypertrophic Osteoarthropathy In affected individuals from 2 Chinese families (6 and 7) segregating autosomal dominant PHO (PHOAD; 167100), Xu et al. (2021) identified heterozygosity for the R603X substitution (c.1807C-T, NM_005630.2) in the SLCO2A1 gene, which was not found in 250 Chinese controls. In family 6, the male proband had complete PHO, with pachydermia, digital clubbing, periostosis, and joint swelling, as well as gastrointestinal abnormalities, whereas his sister and mother, who also carried the R603X variant, exhibited only pachydermia. In family 7, the male proband and his maternal uncle had digital clubbing and periostosis, whereas the proband's mother had only periostosis. (less)
|
|
Pathogenic
(Feb 13, 2024)
|
no assertion criteria provided
Method: literature only
|
PHOAR2-ENTEROPATHY SYNDROME
Affected status: not provided
Allele origin:
germline
|
OMIM
Accession: SCV001738781.4
First in ClinVar: Jun 26, 2021 Last updated: Mar 10, 2024 |
Comment on evidence:
PHOAR2-Enteropathy Syndrome For discussion of the c.1807C-T transition (c.1807C-T, NM_005630) in exon 13 of the SLCO2A1 gene, resulting in an arg603-to-ter (R603X) substitution, that was … (more)
PHOAR2-Enteropathy Syndrome For discussion of the c.1807C-T transition (c.1807C-T, NM_005630) in exon 13 of the SLCO2A1 gene, resulting in an arg603-to-ter (R603X) substitution, that was found in compound heterozygous state in 2 Japanese sisters (patients 4 and 5) with chronic nonspecific ulcers (CNSU) of the stomach, duodenum, and ileum, who also exhibited acne, large joint arthralgias, and hyperhidrosis (PHOAR2E; 614441) by Umeno et al. (2015), see 601460.0004. Umeno et al. (2015) also reported an 18-year-old Japanese girl (patient 15) with anemia and CNSU of the duodenum and ileum who was compound heterozygous for R603X and a splice site mutation in SLCO2A1 (c.940+1G-A; 601460.0005), and a 59-year-old Japanese woman (patient 10) with CNSU of the ileum who was compound heterozygous for R603X and a c.421G-T transversion in exon 4, resulting in a glu141-to-ter (E141X; 601460.0023) substitution. The latter 2 patients did not exhibit features of PHO. Functional analysis in transfected HEK293 cells demonstrated that none of the mutants was able to take up PGE, indicating loss of function as a PGE transporter. For discussion of the c.1807C-T transition (c.1807C-T, NM_005630.2) in exon 13 of the SLCO2A1 gene, resulting in an arg603-to-ter (R603X) substitution, that was found in compound heterozygous state in a 19-year-old Korean man (family 2) with primary hypertrophic osteoarthropathy (PHO) by Lee et al. (2016), see 601460.0005. In 2 Chinese men (P17 and P33) with features of PHO, including digital clubbing and periostosis, Li et al. (2017) identified compound heterozygosity for the R603X substitution and another mutation in the SLCO2A1 gene: in P17, the second mutation was a c.1624C-T transition in exon 11, resulting in an arg542-to-cys (R542C; 601460.0024) substitution at a highly conserved residue; and in P33, the second mutation was a c.1106-1G-A transition in intron 8 (601460.0025). The R542C variant was present at very low minor allele frequency (0.0002221) in the ExAC database. Neither man was reported to have gastrointestinal symptoms. In a review of 46 Japanese patients from 43 families with CNSU and mutation in the SLCO2A1 gene, Umeno et al. (2018) noted that the R603X variant was present in 20 (22%) of 92 alleles, making it the second most frequent mutation identified. In a Chinese man (family 12) with PHO, Xu et al. (2021) identified homozygosity for the R603X substitution. His heterozygous father exhibited only pachydermia and periostosis, whereas his heterozygous mother was clinically unaffected. The proband in family 12 had been previously studied by Li et al. (2017) as P15, and was reported to have gastrointestinal hemorrhage and anemia. Autosomal Dominant Primary Hypertrophic Osteoarthropathy In affected individuals from 2 Chinese families (6 and 7) segregating autosomal dominant PHO (PHOAD; 167100), Xu et al. (2021) identified heterozygosity for the R603X substitution (c.1807C-T, NM_005630.2) in the SLCO2A1 gene, which was not found in 250 Chinese controls. In family 6, the male proband had complete PHO, with pachydermia, digital clubbing, periostosis, and joint swelling, as well as gastrointestinal abnormalities, whereas his sister and mother, who also carried the R603X variant, exhibited only pachydermia. In family 7, the male proband and his maternal uncle had digital clubbing and periostosis, whereas the proband's mother had only periostosis. (less)
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
Monoallelic mutations in SLCO2A1 cause autosomal dominant primary hypertrophic osteoarthropathy. | Xu Y | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research | 2021 | PMID: 33852188 |
Clinical features of chronic enteropathy associated with SLCO2A1 gene: a new entity clinically distinct from Crohn's disease. | Umeno J | Journal of gastroenterology | 2018 | PMID: 29313109 |
Clinical, Biochemical, and Genetic Features of 41 Han Chinese Families With Primary Hypertrophic Osteoarthropathy, and Their Therapeutic Response to Etoricoxib: Results From a Six-Month Prospective Clinical Intervention. | Li SS | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research | 2017 | PMID: 28425581 |
Identification of the Mutations in the Prostaglandin Transporter Gene, SLCO2A1 and Clinical Characterization in Korean Patients with Pachydermoperiostosis. | Lee S | Journal of Korean medical science | 2016 | PMID: 27134495 |
A Hereditary Enteropathy Caused by Mutations in the SLCO2A1 Gene, Encoding a Prostaglandin Transporter. | Umeno J | PLoS genetics | 2015 | PMID: 26539716 |
The complete type of pachydermoperiostosis: a novel nonsense mutation p.E141* of the SLCO2A1 gene. | Niizeki H | Journal of dermatological science | 2014 | PMID: 24929850 |
Three novel mutations in the SLCO2A1 gene in two Chinese families with primary hypertrophic osteoarthropathy. | Cheng R | European journal of dermatology : EJD | 2013 | PMID: 24153155 |
Text-mined citations for rs776813259 ...
HelpRecord last updated Sep 29, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.